颈动脉血运重建术后结局的性别差异:真实世界研究
基于TriNetX数据库的回顾性多中心队列研究分析了59340例颈动脉血运重建术(5599例CAS,53741例CEA),女性占38.0%。倾向性评分匹配调整年龄后,30天时男女性在症状性或无症状患者中CEA和CAS的所有结局均无显著差异;1年时除症状性女性CAS患者生存率较低外(86.7% vs. 93.8%,P=0.013),其余结局无显著差异。
要点
- 30天时男女性在CEA和CAS后死亡、卒中、心梗风险均无显著差异。
- 1年时症状性女性CAS患者生存率显著低于男性(86.7% vs. 93.8%,P=0.013)。
- 其余亚组1年结局男女性无显著差异。
核心结论
- 30天和长期随访中,男女性CEA或CAS后结局无差异,仅症状性女性CAS患者1年生存率较低。
研究设计与样本
- 回顾性多中心队列研究,基于TriNetX平台纳入2010年1月1日至2025年6月19日年龄≥18岁接受CEA或CAS的颈动脉狭窄或闭塞患者。
- 共分析59340例颈动脉血运重建术(5599例CAS,53741例CEA),女性22574例(38.0%)。
- 按症状状态分为4个队列:症状性CAS、症状性CEA、无症状CAS、无症状CEA。
- 主要结局为全因死亡、卒中和心肌梗死的单独及复合结局,比较男女性在术后1个月和1年内的差异,采用倾向性评分匹配调整年龄。
主要发现
- 30天时,倾向性评分匹配调整年龄后,男女性在CEA和CAS队列中(无论症状性还是无症状)所有结局风险均无显著差异。
- 1年时,除症状性女性CAS患者生存率较低外(86.7% vs. 93.8%,P=0.013),其余所有结局在男女性间均无显著差异。
临床怎么用
- 真实世界数据显示颈动脉血运重建术后短期和长期结局总体无性别差异,但症状性女性患者接受CAS后1年生存率较低,需关注该人群的术后管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To analyze the impact of sex on the occurrence of death, stroke, and myocardial infarction at 30 days and at 1 year after either carotid endarterectomy (CEA) or carotid artery stenting (CAS) for the treatment of significant carotid stenosis on the real-world dataset coming from TriNetX. METHODS: A retrospective multicenter cohort study was built within the TriNetX platform (TriNetX LLC, Cambridge, MA) to investigate cohorts of patients aged 18 years or older diagnosed with carotid artery occlusion or stenosis receiving either CEA or CAS from January 1, 2010 to June 19, 2025. Patients were also classified as symptomatic, thus delineating 4 cohorts: symptomatic CAS, symptomatic CEA, asymptomatic CAS, and asymptomatic CEA. The primary outcome was identified as the occurrence of death from all causes, stroke and myocardial infarction, within each of the 4 cohorts of patients, comparing male versus female patients. These outcomes were evaluated both individually and as a composite outcome within 1 month and 1 year after the intervention. RESULTS: The results of 59,340 procedures of carotid revascularization (5599 CAS and 53,741 CEA) from 2010 ongoing were analyzed, being 22,574 on female patients (38.0%). At 30 days, the propensity-matched score analysis adjusted for age did not show any significant difference for the risk of all the outcomes between males and females both in the cohort of patients who underwent CEA as well as in that of patients who underwent CAS, neither in symptomatic nor in asymptomatic patients. At 1 year, no significant differences were recorded between men and women for the all the outcomes in both the cohorts, except for a lower survival of symptomatic female patients who underwent CAS (86.7% vs. 93.8%, P = 0.013). CONCLUSION: At 30 days and at long-term follow-up, no differences were recorded between male and female patients undergoing CAS or CEA, except for a lower 1-year survival of symptomatic female patients who underwent CAS.
引用
- Mazzaccaro D, Boveri S, Girani E, et al. Sex Differences in the Outcomes after Carotid Revascularization in Real-World Experience. Ann Vasc Surg. 2026. PMID: 41643843. doi:10.1016/j.avsg.2026.01.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。